How does baseline anthropometry affect anthropometric outcomes in children receiving treatment for severe acute malnutrition? A secondary analysis of a randomized controlled trial.


Journal

Maternal & child nutrition
ISSN: 1740-8709
Titre abrégé: Matern Child Nutr
Pays: England
ID NLM: 101201025

Informations de publication

Date de publication:
07 2022
Historique:
revised: 20 01 2022
received: 28 07 2021
accepted: 21 01 2022
pubmed: 15 2 2022
medline: 25 6 2022
entrez: 14 2 2022
Statut: ppublish

Résumé

Mid-upper arm circumference (MUAC) < 11.5 cm and weight-for-height Z-score (WHZ) < -3 are used for screening for severe acute malnutrition (SAM). Underweight and concurrent wasting and stunting may better target those at the highest risk of mortality. We compared anthropometric outcomes in children enrolled in a trial of antibiotics for SAM based on categories of baseline anthropometry, including indicators for programme admission (WHZ < -3, MUAC < 11.5) and alternative indicators (weight-for-age Z-score [WAZ] < -3, concurrent wasting and stunting [WHZ < -3 and height-for-age Z-score < -3]). Participants were followed weekly until nutritional recovery and at 8 weeks. We evaluated changes in weight gain (g/kg/day), MUAC, and WHZ in children admitted by admissions criteria (MUAC only, WHZ only, or MUAC and WHZ) and by underweight or concurrent wasting and stunting. Of 301 admitted children, 100 (33%) were admitted based on MUAC only, 41 (14%) WHZ only, and 160 (53%) both MUAC and WHZ, 210 (68%) were underweight and 67 (22%) were concurrently wasted/stunted. Low MUAC and low WHZ children had the lowest probability of nutritional recovery (17% vs. 50% for MUAC-only and 34% for WHZ-only). There was no difference in weight gain velocity or WHZ by admissions criteria (WHZ and/or MUAC). Underweight and concurrently wasted/stunted children had lower MUAC and WHZ at 8 weeks compared with those who were not underweight or concurrently wasted and stunted. Children with both low MUAC and low WHZ had the worst outcomes. Relying on MUAC alone may miss children who have poor outcomes. Other indicators, such as WAZ, may be useful for identifying vulnerable children.

Identifiants

pubmed: 35157777
doi: 10.1111/mcn.13329
pmc: PMC9218313
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13329

Subventions

Organisme : NICHD NIH HHS
ID : R21 HD100932
Pays : United States

Informations de copyright

© 2022 The Authors. Maternal & Child Nutrition published by John Wiley & Sons Ltd.

Références

Matern Child Nutr. 2022 Jul;18(3):e13329
pubmed: 35157777
PLoS One. 2014 Jul 01;9(7):e101159
pubmed: 24983995
Nutr J. 2018 Sep 15;17(1):79
pubmed: 30217205
PLoS One. 2019 Aug 6;14(8):e0219745
pubmed: 31386678
Am J Trop Med Hyg. 2022 Jan 10;106(3):930-938
pubmed: 35008055
Pilot Feasibility Stud. 2021 Apr 20;7(1):97
pubmed: 33879263
Arch Public Health. 2016 Sep 06;74(1):38
pubmed: 27602207
J Trop Pediatr. 2017 Aug 1;63(4):260-266
pubmed: 28082667
BMJ Glob Health. 2020 Nov;5(11):
pubmed: 33208313
Trans R Soc Trop Med Hyg. 2013 May;107(5):319-23
pubmed: 23471920
Am J Trop Med Hyg. 2021 Sep 27;106(1):351-355
pubmed: 34583344
Pediatrics. 2021 Jun;147(6):
pubmed: 34021063
Public Health Nutr. 2015 Oct;18(14):2575-81
pubmed: 25805273
Ann Hum Biol. 2009 Jan-Feb;36(1):5-20
pubmed: 19085192
Public Health Nutr. 2020 Feb;23(3):538-543
pubmed: 31496465
Matern Child Nutr. 2012 Jan;8(1):130-3
pubmed: 21951349
PLoS One. 2012;7(11):e49320
pubmed: 23189140
Am J Trop Med Hyg. 2021 Oct 25;106(1):361-368
pubmed: 34695800
Lancet. 2013 Aug 17;382(9892):587-8
pubmed: 23961550
JAMA. 2005 Aug 3;294(5):591-7
pubmed: 16077053

Auteurs

Clarisse Dah (C)

Centre de Recherche en Santé de Nouna, Nouna, Burkina Faso.

Millogo Ourohire (M)

Centre de Recherche en Santé de Nouna, Nouna, Burkina Faso.

Ali Sié (A)

Centre de Recherche en Santé de Nouna, Nouna, Burkina Faso.

Moussa Ouédraogo (M)

Centre de Recherche en Santé de Nouna, Nouna, Burkina Faso.

Mamadou Bountogo (M)

Centre de Recherche en Santé de Nouna, Nouna, Burkina Faso.

Valentin Boudo (V)

Centre de Recherche en Santé de Nouna, Nouna, Burkina Faso.

Elodie Lebas (E)

Francis I Proctor Foundation, University of California, San Francisco, California, USA.

Fanice Nyatigo (F)

Francis I Proctor Foundation, University of California, San Francisco, California, USA.

Benjamin F Arnold (BF)

Francis I Proctor Foundation, University of California, San Francisco, California, USA.
Department of Ophthalmology, University of California, San Francisco, California, USA.

Kieran S O'Brien (KS)

Francis I Proctor Foundation, University of California, San Francisco, California, USA.

Catherine E Oldenburg (CE)

Francis I Proctor Foundation, University of California, San Francisco, California, USA.
Department of Ophthalmology, University of California, San Francisco, California, USA.
Department of Epidemiology & Biostatistics, University of California, San Francisco, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH